These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 2803677)

  • 1. The effect of acute and subchronic treatment with cicletanine on DOCA-salt hypertension in the rat.
    Fuentes JA; Castro A; Alsasua A
    Am J Hypertens; 1989 Sep; 2(9):718-20. PubMed ID: 2803677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The antihypertensive agent cicletanine reverses vascular hyperreactivity to noradrenaline and cardiac hypertrophy in DOCA-salt rats.
    Castro A; Parra L; Alsasua A; Fuentes JA
    Arch Int Pharmacodyn Ther; 1990; 307():109-18. PubMed ID: 2151359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on the mechanism of action of the antihypertensive agent cicletanine.
    Castro A; Parra L; Fuentes JA
    Arch Mal Coeur Vaiss; 1989 Nov; 82 Spec No 4():51-4. PubMed ID: 2514669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of cicletanine on cerebrovascular injury in stroke-prone spontaneously hypertensive rats.
    Ruchoux MM; Huguet F; Droy-Lefaix MT; Gelot A; Ruchoux P; Autret A
    Am J Hypertens; 1989 Sep; 2(9):683-9. PubMed ID: 2803675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of cicletanine with other antihypertensive drugs in SHR-SP models.
    Malherbe E; Le Hegarat M; Clostre F; Braquet P
    Drugs Exp Clin Res; 1988; 14(2-3):83-8. PubMed ID: 2970955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Further evidence for a peripheral sympathicolytic action of the antihypertensive cicletanine in rats.
    Castro A; Hernando F; Parra L; Puerro M; Aleixandre A; Fuentes JA
    Drugs Exp Clin Res; 1995; 21(1):29-36. PubMed ID: 7796710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antihypertensive effect of non-diuretic doses of cicletanine on a stress-induced model in the rat.
    Castro A; Florentino A; Fuentes JA
    Drugs Exp Clin Res; 1988; 14(2-3):97-101. PubMed ID: 3416728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of cicletanine on reperfusion-induced arrhythmias and myocardial ion contents: a comparison with furosemide.
    Koltai M; Tosaki A; Berthet P; Tarrade T; Esanu A; Braquet P
    Eur Heart J; 1992 Mar; 13(3):395-403. PubMed ID: 1597228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antihypertensive profile of cicletanine, a furopyridine derivative: comparison with captopril, indapamide and prazosin.
    Malherbe E; Auguet M; Delaflotte S; Le Hégarat M; Baranes J; Clostre F; Braquet P
    Pharmacol Res Commun; 1988 Sep; 20 Suppl 3():121-33. PubMed ID: 2976170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cicletanine improves myocardial function deteriorated by ischemia/reperfusion in isolated working rat hearts.
    Ferdinandy P; Koltai M; Tosaki A; Berthet P; Tarrade T; Esanu A; Braquet P
    J Cardiovasc Pharmacol; 1992 Feb; 19(2):181-9. PubMed ID: 1376786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for medial-mass regression in the vascular wall of Dahl hypertensive rats by cicletanine treatment.
    Uehara Y; Numabe A; Kawabata Y; Nagata T; Iwai J; Matsuoka H; Yagi S; Takabatake Y; Sugimoto T
    J Cardiovasc Pharmacol; 1991 Jul; 18(1):158-66. PubMed ID: 1719285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emblica officinalis exerts antihypertensive effect in a rat model of DOCA-salt-induced hypertension: role of (p) eNOS, NO and oxidative stress.
    Bhatia J; Tabassum F; Sharma AK; Bharti S; Golechha M; Joshi S; Sayeed Akhatar M; Srivastava AK; Arya DS
    Cardiovasc Toxicol; 2011 Sep; 11(3):272-9. PubMed ID: 21748534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Review of three studies to determine the efficacy and tolerance of cicletanine in the short- and long-term treatment of essential hypertension.
    Fodor GP; Guinot P
    Drugs Exp Clin Res; 1988; 14(2-3):195-204. PubMed ID: 3046883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo and in vitro effects of cicletanine in spontaneously hypertensive rats.
    Auguet M; Guillon JM; Delaflotte S; Le Hegarat M; Pirotzky E; Clostre F; Braquet P
    Drugs Exp Clin Res; 1988; 14(2-3):89-95. PubMed ID: 3416727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The antihypertensive effect of taurine in DOCA-salt rats.
    Fujita T; Sato Y
    J Hypertens Suppl; 1984 Dec; 2(3):S563-5. PubMed ID: 6152784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Left ventricular compliance in the DOCA-salt model of hypertension in the rat. Effects of propranolol.
    Cheav SL; Delcayre C; Besnard JC; Paolaggi F; Mouas C; Swynghedauw B
    Arch Int Pharmacodyn Ther; 1991; 314():5-24. PubMed ID: 1840461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Attenuation of cardiovascular remodeling in DOCA-salt rats by the vasopeptidase inhibitor, omapatrilat.
    Loch D; Hoey A; Brown L
    Clin Exp Hypertens; 2006 Jul; 28(5):475-88. PubMed ID: 16820344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nitric oxide, peroxynitrite and cGMP in atherosclerosis-induced hypertension in rabbits: beneficial effects of cicletanine.
    Szilvássy Z; Csont T; Páli T; Droy-Lefaix MT; Ferdinandy P
    J Vasc Res; 2001; 38(1):39-46. PubMed ID: 11173993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of cicletanine on vasoactive systems in conscious sinoaortic-denervated dogs.
    Damase-Michel C; Girolami JP; Bascands JL; Tran MA; Moatti JP; Pecher C; Berthet P; Tarrade T; Montastruc JL
    Fundam Clin Pharmacol; 1991; 5(8):719-32. PubMed ID: 1783361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Efficacy and tolerability of cycletanine in aged patients with hypertension].
    Bodak A; Gavardin T; Salom M; Tarrade T; Forette F; Jungers P; Metellus J
    Therapie; 1989; 44(2):101-6. PubMed ID: 2756515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.